Expression of Fos protein in various rat brain areas following acute nicotine and diazepam

Pharmacology Biochemistry and Behavior

Volumn 54, Issue 1, 1996, Pages 241-248

  Salminen, Outi ^a   Lahtinen, Sirpa ^a   Ahtee, Liisa ^a  

^a Div of Pharmacology and Toxicology   (Finland)

Author keywords

c fos; diazepam; immunohistochemistry; nicotine; stress

Indexed keywords

DIAPAM; DIAZEPAM; HEXAMETHONIUM; NICOTINE; PROTEIN C FOS; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; BRAIN REGION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ANTAGONISM; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; IMMUNOHISTOCHEMISTRY; INTERPEDUNCULAR NUCLEUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; OPTIC TRACT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STRESS; SUBCUTANEOUS DRUG ADMINISTRATION; SUPRAOPTIC NUCLEUS;

EID: 0029898083     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02132-9     Document Type: Conference Paper

References (37)

1. Amstrong, M.E. Cholinergic innervation of vasopressin-containing neurons in the supraoptic nucleus of the rat. In: Schrier, R. W., ed. Vasopressin. New York: Raven Press; 1985: 353-360.
2. Andersson, K.; Siegel, R.; Fuxe, K.; Eneroth, P. Intravenous injections of nicotine induce very rapid and discrete reductions of hypothalamic catecholamine levels associated with increases of ACTH, vasopressin and prolactin secretion. Acta Physiol. Scand. 118:35-40; 1983.
3. Arnold, F. J. L.; De Lucas Bueno, M.; Shiers, H.; Hancock, D. C.; Evan, G. I.; Herbert, J. Expression of c-fos in regions of the basal limbic forebrain following intracerebroventricular corticotropin-releasing factor in unstressed or stressed male rats. Neuroscience 51:377-390; 1992.
4. Beck, C. H.; Fibiger, H. C. Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: With and without diazepam pretreatment. J. Neurosci. 15(1 Pt. 2):709-720; 1995.
5. Brown, M. R.; Gray, T. S. Peptide injections into the amygdala of conscious rats: Effects on blood pressure, heart rate and plasma catecholamines. Regul. Pept. 21:95-106; 1988.
6. Bullitt, E. Expression of c-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat. J. Comp. Neurol. 296:517-530; 1990.
7. Campeau, S.; Hayward, M. D.; Hope, B. T.; Rosen, J. B.; Nestler, E. J.; Davis, M. Induction of the c-fos proto-oncogene in rat amygdala during unconditioned and conditioned fear. Brain Res. 565:349-352; 1991.
8. Ceccatelli, S.; Villar, M. J.; Goldstein, M.; Hökfelt, T. Expression of c-fos immunoreactivity in transmitter-characterized neurons after stress. Proc. Natl. Acad. Sci. USA 86:9569-9573; 1989.
9. 125I]-a-bungarotoxin. J. Neurosci. 5:1307-1315; 1985.
10. Curran, T.; Franza, B. R. Fos and Jun: The AP-1 connection. Cell 55:395-397; 1988.
11. Curran, T.; Morgan, J. Superinduction of c-fos by nerve growth factor in the presence of peripherally active benzodiazepines. Science 229:1265-1268; 1985.
12. Deutch, A. Y.; Lee, M. C.; Gillham, M. H.; Cameron, D. A.; Goldstein, M.; Iadarola, M. J. Stress selectively increases fos protein in dopamine neurons innervating the prefrontal cortex. Cereb. Cortex 1:273-292; 1991.
13. Dragunow, M.; Faull, R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J. Neurosci. Methods 29:261-265; 1989.
14. Dunn, J. D.; Whitener, J. Plasma corticosterone responses to electrical stimulation of the amygdaloid complex: Cytoarchitectural specificity. Neuroendocrinology 42:211-217; 1986.
15. Hayhow, W. R.; Webb, C.; Jervie, A. The accessory optic fiber system in the rat. J. Comp. Neurol. 115:187-215; 1960.
16. Honkaniemi, J.; Kainu, T.; Ceccatelli, S.; Rechardt, L.; Hökfelt, T.; Pelto-Huikko, M. Fos and Jun in rat central amygdaloid nucleus and paraventricular nucleus after stress. Neuroreport 3: 849-852; 1992.
17. Hunt, S. P.; Pini, A.; Evan, G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 328: 632-634; 1987.
18. Ichikawa, T.; Hirata, Y. Organization of choline acetyltransferase-containing structures in the forebrain of the rat. J. Neurosci. 6:281-292; 1986.
19. London, E. D.; Connolly, R. J.; Szikszay, M.; Wamsley, J. K.; Dam, M. Effects of nicotine on local cerebral glucose utilization in the rat. J. Neurosci. 8:3920-3928; 1988.
20. 3H]-nicotine binding sites in the rat brain. Neurosci. Lett. 53:179-184; 1985.
21. Matta, S. G.; Foster C. A.; Sharp B. M. Nicotine stimulates the expression of c-fos protein in the parvocellular paraventricular nucleus and brainstem catecholaminergic regions. Endocrinology 132(5):2149-2156; 1993.
22. Moore, R. Y.; Bloom, F. E. Central catecholamine neuron systems: Anatomy and physiology of the norepinephrine and epinephrine systems. Annu. Rev. Neurosci. 2:113-168; 1979.
23. Pang, Y.; Kiba, H.; Jayaraman, A. Acute nicotine injections induce c-fos mostly in nondopaminergic neurons of the midrain of the rat. Mol. Brain. Res. 20:162-170; 1993.
24. Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates. New York: Academic Press; 1986.
25. Peričić, D.; Lacić, N.; Manev, H. Effect of diazepam on plasma corticosterone levels. Psychopharmacology 83:79-81; 1984.
26. Prouxl, L.; Giguere, V.; Levefre, G.; Labrie, F. Interactions between catecholamines, CRF and vasopressin in the control of ACTH secretion in the rat. In: Usdin, E.; Kvetnansky, R.; Axelrod, J., eds. Stress: The role of catecholamines and other neurotransmitters. Vol. 1. New York: Gordon and Breach Sci. Publ.; 1984:211-224.
27. Ren, T.; Sagar, S. M. Induction of c-fos immunostaining in the rat brain after the systemic administration of nicotine. Brain Res. Bull. 29:589-597; 1992.
28. Robertson, G.; Herrera, D.; Dragunow, M., Robertson, H. L-DOPA activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra. Eur. J. Pharmacol. 159:99-100; 1989.
29. Sagar, S. M.; Sharp, F. R.; Curran, T. Expression of c-fos protein in brain: Metabolic mapping at the cellular level. Science 240: 1328-1331; 1988.
30. Semba, K.; Fibiger, H. C. Organization of central cholinergic system. In: Nordberg, A.; Fuxe, K.; Holmstedt, B.; Sundwall, A., eds. Progress in brain research. Vol. 79. Amsterdam: Elsevier; 1989:37-63.
31. Sharp, B. M.; Beyer, S. H.; McAllen, K. M.; Hart, D.; Malta, S. G. Induction and desensitization of the c-fos mRNA response to nicotine in rat brain. Mol. Cell. Neurosci. 4:199-208; 1993.
32. Sharp, F. R.; Sagar, S. M.; Hicks, K.; Lowenstein, D.; Hisanaga, K. c-fos mRNA, Fos and Fos-related antigen induction by hypertonic saline and stress. J. Neurosci. 11(8):2321-2331; 1991.
33. Straaten, F.-V.; Muller, R.; Curran, T.; Beveren, C.-V., Verma, I. M. Complete nucleotide sequence of a human c-onc-gene: Deduced amino acid sequence of the human c-fos protein. Proc. Natl. Acad. Sci. USA 80:3183-3187; 1983.
34. Vale, W.; Spiess, J.; Rivier, C.; Rivier, J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213:1394-1397; 1981.
35. 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the rat. J. Comp. Neurol. 284:341-335; 1989.
36. Woolf, N. J.; Butcher, L. L. Cholinergic systems in the rat brain: 2. Projections to the interpeduncular nucleus. Brain Res. Bull. 14:63-83; 1985.
37. Zbuzek, V. K.; Zbuzek, V. Effect of chronic nicotine treatment and its withdrawal on the vasopressinergic system in rats. J. Neuroendocrinol. 3:107-112; 1991.